With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
"The vaccine pushed back about 75 percent of the cancer," the dog owner, tech entrepreneur Paul Conyngham, said.
HHS plans 200M cancer vaccine initiative to fund public-private partnerships studying vaccines for high-risk cancer patients.
Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the ...
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
Paul Conyngham, an Australian technology enthusiast, developed a custom mRNA vaccine for his cancer-stricken dog, Rosie.
One dog dad decided to take matters into his own hands using an unlikely skill to help his dog—and the results were ...
Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines ...
When 12-year-olds receive a letter from the school nurse about the HPV vaccine, their reactions are often mixed. Some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results